| 发明名称 | Use of TNFα inhibitor for treatment of psoriatic arthritis | ||
| 摘要 | The invention describes methods of treating erosive polyarthritis comprising administering a TNFα antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNFα antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis. | ||
| 申请公布号 | US9085620(B1) | 申请公布日期 | 2015.07.21 |
| 申请号 | US201514681713 | 申请日期 | 2015.04.08 |
| 申请人 | AbbVie Biotechnology Ltd. | 发明人 | Hoffman Rebecca S.;Weinberg Mark;Banerjee Subhashis;Taylor Lori K.;Spiegler Clive E.;Tracey Daniel E.;Chartash Elliot K.;Barchuk William T.;Yan Philip;Murtaza Anwar;Salfeld Jochen G.;Fischkoff Steven A.;Granneman George R. |
| 分类号 | C07K16/28;A61K39/395;C07K16/24 | 主分类号 | C07K16/28 |
| 代理机构 | Foley Hoag LLP | 代理人 | Foley Hoag LLP |
| 主权项 | 1. A method of administering adalimumab for treatment of psoriatic arthritis, comprising filling adalimumab into vessels and subcutaneously administering 40 mg of said adalimumab to a patient having psoriatic arthritis every other week. | ||
| 地址 | Hamilton BM | ||